Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-08-01

FDA Approved: CLEVIPREX — Original Application (Fresenius Kabi Austria GmbH)

View source ↗

Summary

FDA approved CLEVIPREX (clevidipine) from Fresenius Kabi Austria GmbH in an Original Application (NDA022156) for short-term intravenous management of acute hype…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLEVIPREX (clevidipine)

Snippet

ORIG AP for CLEVIPREX (CLEVIDIPINE)